Mydrate Eye Drop 10 mg/ml contains Cyclopentolate Hydrochloride, a well-established anticholinergic agent widely used in ophthalmology for diagnostic and therapeutic purposes. It is primarily indicated for inducing mydriasis (pupil dilation) and cycloplegia (temporary paralysis of accommodation), making it an essential medication for accurate eye examinations and certain ocular treatments.

Cyclopentolate Hydrochloride works by blocking muscarinic receptors in the sphincter muscle of the iris and the ciliary body. This action leads to dilation of the pupil and relaxation of the ciliary muscle, allowing ophthalmologists to clearly examine the retina, optic nerve, and other internal eye structures. The effect typically begins within 30–60 minutes and lasts for several hours, depending on individual response and dosage.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Mydrate Eye Drop is indicated for the following ophthalmic uses:

• Induction of mydriasis and cycloplegia for refraction testing

• Diagnostic examination of the retina and fundus

• Preoperative and postoperative ocular procedures

• Management of anterior uveitis and iritis to relieve pain and prevent synechiae

Dosage and Administration

Mydrate Eye Drop is for topical ophthalmic use only. The dosage and frequency depend on the purpose of use and the patient’s age and condition. It should be instilled into the conjunctival sac as prescribed by an ophthalmologist. Care should be taken to avoid contamination of the dropper tip, and patients are advised to apply gentle pressure on the nasolacrimal duct after instillation to minimize systemic absorption.

Key Benefits

• Rapid and effective pupil dilation

• Provides reliable cycloplegia for accurate refraction

• Widely used and clinically proven in ophthalmic practice

• Suitable for diagnostic and therapeutic applications

• Helps reduce pain and inflammation in certain eye conditions

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• For ophthalmic use only; not for injection or oral use

• Use with caution in patients with glaucoma or risk of increased intraocular pressure

• Pediatric and elderly patients may be more sensitive to systemic effects

• Temporary blurred vision and light sensitivity may occur; patients should avoid driving until vision clears

• Prolonged or excessive use should be avoided

Adverse Effects

Possible side effects associated with Cyclopentolate Hydrochloride include:

• Transient stinging or burning sensation in the eye

• Blurred vision and photophobia

• Eye redness or irritation

• Dry mouth or flushing due to systemic absorption (rare)

• Increased intraocular pressure in susceptible individuals

Most adverse effects are temporary and resolve without intervention.

Storage Conditions

Store Mydrate Eye Drop below 30°C, protected from light. Do not freeze. Keep the bottle tightly closed when not in use and out of reach of children. Discard the product after the recommended period following first opening.

Conclusion

Mydrate Eye Drop 10 mg/ml (Cyclopentolate Hydrochloride) is a reliable and widely used ophthalmic solution for inducing mydriasis and cycloplegia. Its proven efficacy, rapid onset of action, and established safety profile make it an essential tool for eye examinations and selected ocular treatments under professional supervision.